Fig. 1 | Scientific Reports

Fig. 1

From: Investigation of the cytotoxic effects and mechanisms of the SLC39A6-targeting ADC drug BRY812 in CRC

Fig. 1

SLC39 A6 is highly expressed in CRC tissues. (A) Barplot illustrates the expression levels of SLC39A6 in tumor and normal tissues within the TCGA-COAD, GSE33113 and GSE39582 cohort. (B) tSNE plot showing the transcriptome landscape, which consists of 21 cell clusters. Dot plot and violin plot depicting the expression of SLC39A6 in normal, border and tumor tissues in CRC. (C) Spatial transcriptomics (ST) map of normal and tumor tissues in CRC. (D) umap plot showing all the spots of three slides. (E) The dot plot depictes expression of SLC39A6 on slides. (F) Barplot illustrates the expression levels of SLC39A6 in tumor and normal tissues within the slides. The statistical difference was compared through the Wilcox test. *P < 0.05; **P < 0.01; ***P < 0.001.

Back to article page